104 related articles for article (PubMed ID: 20209590)
1. Human leukocyte antigen crossmatch testing is important for liver retransplantation.
Goh A; Scalamogna M; De Feo T; Poli F; Terasaki PI
Liver Transpl; 2010 Mar; 16(3):308-13. PubMed ID: 20209590
[TBL] [Abstract][Full Text] [Related]
2. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen antibodies in liver retransplantation.
Zeevi A; Lunz JG
Liver Transpl; 2010 Mar; 16(3):259-61. PubMed ID: 20209587
[No Abstract] [Full Text] [Related]
5. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of HLA Matchmaker compatibility as predictor of graft survival and presence of Anti-HLA antibodies.
Silva E; Alba A; Castro A; Carrascal M; Buckel E; Aguiló J; Herzog C; Calabrán L; Morales J; Fierro JA
Transplant Proc; 2010; 42(1):266-9. PubMed ID: 20172326
[TBL] [Abstract][Full Text] [Related]
7. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
[TBL] [Abstract][Full Text] [Related]
9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
10. Cadaver-donor renal retransplants.
Cho YW; Cecka JM
Clin Transpl; 1993; ():469-84. PubMed ID: 7918181
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children.
Stastny P; Lavingia B; Fixler DE; Yancy CW; Ring WS
Transplantation; 2007 Sep; 84(6):738-45. PubMed ID: 17893607
[TBL] [Abstract][Full Text] [Related]
12. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
13. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
[TBL] [Abstract][Full Text] [Related]
14. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
[TBL] [Abstract][Full Text] [Related]
15. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
[TBL] [Abstract][Full Text] [Related]
16. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
[TBL] [Abstract][Full Text] [Related]
17. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
18. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
[TBL] [Abstract][Full Text] [Related]
19. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
[TBL] [Abstract][Full Text] [Related]
20. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]